21-hydroxyepothilone D

N/A

Report date: 2026/03/06 20:02:51
NME

Base Information

Drug Name21-hydroxyepothilone D
Drug Alias NameDesoxyepothilone F12,13-desoxyepothilone F21-hydroxy-12,13-desoxyepothilone BdEpoF
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitosis inhibitorsTubulin depolymerization inhibitors
TargetsTubulin
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMemorial Sloan Kettering Cancer Center
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMemorial Sloan Kettering Cancer Center
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A